tiprankstipranks
Clinigence Holdings (NUTX)
NASDAQ:NUTX
US Market

Clinigence Holdings (NUTX) Technical Analysis

Compare
201 Followers

Technical Sentiment

Overall Consensus
Buy
15Bullish
1Neutral
6Bearish
Technical Analysis Consensus
Sell
3Bullish
1Neutral
6Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Clinigence Holdings’s (NUTX) Moving Averages Convergence Divergence (MACD) indicator is 4.62, suggesting Clinigence Holdings is a Sell.
Clinigence Holdings’s (NUTX) 20-Day exponential moving average is 42.41, while Clinigence Holdings’s (NUTX) share price is $59.35, making it a Buy.
Clinigence Holdings’s (NUTX) 50-Day exponential moving average is 36.80, while Clinigence Holdings’s (NUTX) share price is $59.35, making it a Buy.

Clinigence Holdings (NUTX) Pivot Points

Feb 07, 2025, 11:51 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
44.94
46.12
47.40
48.58
49.86
51.04
52.32
Fibonacci
46.12
47.06
47.64
48.58
49.52
50.10
51.04
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Clinigence Holdings (NUTX) Moving Averages

Feb 07, 2025, 11:51 AM
Period
Simple
Exponential
MA5
49.62Buy
49.80Buy
MA10
45.96Buy
46.51Buy
MA20
40.16Buy
42.41Buy
MA50
36.51Buy
36.80Buy
MA100
30.24Buy
31.23Buy
MA200
19.84Buy
23.13Buy
Clinigence Holdings’s (NUTX) 10-Day exponential moving average is 46.51, while Clinigence Holdings’s (NUTX) share price is $59.35, making it a Buy.
Clinigence Holdings’s (NUTX) 100-Day exponential moving average is 31.23, while Clinigence Holdings’s (NUTX) share price is $59.35, making it a Buy.
Clinigence Holdings’s (NUTX) stock price is $59.35 and Clinigence Holdings’s (NUTX) 50-day simple moving average is 36.51, creating a Buy signal.
Clinigence Holdings’s (NUTX) stock price is $59.35 and Clinigence Holdings’s (NUTX) 100-day simple moving average is 30.24, creating a Buy signal.
Clinigence Holdings’s (NUTX) stock price is $59.35 and Clinigence Holdings’s (NUTX) 200-day simple moving average is 19.84, creating a Buy signal.

Clinigence Holdings (NUTX) Technical Indicators

Feb 07, 2025, 11:51 AM
Name
Value
Implied Action
RSI (14)
80.99
Sell
STOCH (9,6)
95.06
Sell
STOCHRSI (14)
96.26
Sell
MACD (12,26)
4.62
Sell
ADX (14)
27.46
Neutral
Williams %R
-1.73
Sell
CCI (14)
159.34
Sell
ATR (14)
3.62
-
Ultimate Oscillator
76.69
Buy
ROC
68.03
Buy
Clinigence Holdings’s (NUTX) Relative Strength Index (RSI) is 80.99, creating a Sell signal.
Clinigence Holdings’s (NUTX) Trend Strength Indicator (ADX) is 27.46, creating a Neutral signal.
Clinigence Holdings’s (NUTX) Commodity Channel Index (CCI) is 159.34, creating a Sell signal.
Clinigence Holdings’s (NUTX) Price Rate of Change (ROC) is 68.03, creating a Buy signal.

FAQ

Is NUTX a Buy, Hold, or Sell?
Based on NUTX’s technical indicators, NUTX is a Buy.
    What is NUTX’s RSI (14)?
    NUTX’s RSI (14) is 80.99, which suggests NUTX is a Sell.
      What is NUTX’s MACD?
      NUTX’s MACD is 4.62, which suggests NUTX is a Sell.
        What is NUTX’s 5-day moving average?
        NUTX’s 5-day moving average is 49.62, which suggests NUTX is a Buy.
          What is NUTX’s 20-day moving average?
          NUTX 20-day moving average is 40.16, which suggests NUTX is a Buy.
            What is NUTX’s 50-day moving average?
            NUTX’s 50-day moving average is 36.51, which suggests NUTX is a Buy.
              What is NUTX’s 200-day moving average?
              NUTX’s 200-day moving average is 19.84, which suggests NUTX is a Buy.
                What is NUTX’s Williams % R (14)?
                NUTX’s Williams % R (14) is -1.73, which suggests NUTX is a Sell.
                  What is NUTX’s CCI (14)?
                  NUTX’s CCI (14) is 159.34, which suggests NUTX is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis